CAS No. |
1965291-08-0 |
|---|---|
中文名称 |
(1S,2R,3R,4aR,6aS,7R,8R,10aR,10bR,12aR)-2-((R)-2-氨基-2,3,3-三甲基丁氧基)-1,6a,8,10a-四甲基-8-((R)-3-甲基丁-2-基)-3-(5-(吡啶-4-基)-1H-1,2,4-三唑-1-基)-1,3,4,6,6a,7,8,9,10,10a,10b,11,12,12a-十四氢-2H-1,4a-(亚甲氧基亚甲基)䓛-7-羧酸与2-羟基丙烷-1,2,3-三羧酸的化合物(1:1) |
英文名称 |
(1S,2R,3R,4aR,6aS,7R,8R,10aR,10bR,12aR)-2-((R)-2-amino-2,3,3-trimethylbutoxy)-1,6a,8,10a-tetramethyl-8-((R)-3-methylbutan-2-yl)-3-(5-(pyridin-4-yl)-1H-1,2,4-triazol-1-yl)-1,3,4,6,6a,7,8,9,10,10a,10b,11,12,12a-tetradecahydro-2H-1,4a-(methanooxymethano)chrysene-7-carboxylic acid compound with 2-hydroxypropane-1,2,3-tricarboxylic acid (1:1) |
别名 |
Ibrexafungerp citrate | GLXC-26020 | Ibrexafungerp citrate [USAN] | brexafemme | D11545 | 4H-1,4A-PROPANO-2H-PHENANTHRO(1,2-C)PYRAN-7-CARBOXYLIC ACID, 15-((2R)-2-AMINO-2,3,3-TRIMETHYLBUTOXY)-8-((1R)-1,2-DIMETHYLPROPYL)-1,6,6A,7,8,9,10,10A,10B,11,12,12A-DO |
标准英文名 |
(1S,2R,3R,4aR,6aS,7R,8R,10aR,10bR,12aR)-2-((R)-2-amino-2,3,3-trimethylbutoxy)-1,6a,8,10a-tetramethyl-8-((R)-3-methylbutan-2-yl)-3-(5-(pyridin-4-yl)-1H-1,2,4-triazol-1-yl)-1,3,4,6,6a,7,8,9,10,10a,10b,11,12,12a-tetradecahydro-2H-1,4a-(methanooxymethano)chrysene-7-carboxylic acid--2-hydroxypropane-1,2,3-tricarboxylic acid (1/1) |
分子式 |
C44H67N5O4.C6H8O7 |
分子量 |
921.55 |
精确分子量 |
921.55 |
SMILES |
OC(CC(C(O)=O)(O)CC(O)=O)=O.C[C@@]12[C@@]3([H])[C@@](C[C@@H](N4C(C5=CC=NC=C5)=NC=N4)[C@@H]1OC[C@](C)(N)C(C)(C)C)(COC2)C6=CC[C@@](C)([C@@H]([C@](C)(CC7)[C@H](C)C(C)C)C(O)=O)[C@@]7(C)[C@@]6([H])CC3 |
标准SMILES |
CC(C)(C)[C@@](C)(N)CO[C@H]1[C@@H](C[C@@]23COC[C@]1(C)[C@@H]2CC[C@H]1C3=CC[C@@]2(C)[C@H](C(O)=O)[C@](C)(CC[C@@]21C)[C@H](C)C(C)C)N1N=CN=C1C1C=CN=CC=1.OC(CC(O)=O)(CC(O)=O)C(O)=O |
用途 |
Ibrexafungerp citrate is used for the treatment of Candida and Aspergillus infections. |
InChIKey |
WKIRTJACGBEXBZ-FQGZCCSZSA-N |
|
|
评论 |
|---|